Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LYNNTECH INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- PMVAL8J63516
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Many reported risks and hazards in
hemodialysis are associated with water quality, including pyrogenic
contamination. The typical patient on dialysis is exposed to between 30 to 40
times the amount of water to which a member of the general population is
exposed. Thus, the quality of hemodialysis water is obviously very important.
Current practices in hemodialysis systems do not guarantee pyrogen-free water.
Several drawbacks exist in using available procedures to achieve pyrogen-free
water: (i) addition of chemicals, which have to be monitored and destroyed
before the water contacts the dialysis membrane. Otherwise, the chemicals may
come in contact with the patient about blood; (ii) formation of toxic
by-products from the reaction of pyrogens with the disinfectant; (iii) no
on-line means of providing pyrogen-free water (i.e., batch-mode operation), and
(iv) cost. This project concerns the development and evaluation of an
efficient, fast, and cost-effective photoreactor to supply pyrogen-free water
on-line in hemodialysis system. The disinfecting agents are short-lived
hydroxyl radicals, one of the strongest oxidants known, which are produced
in-situ, and consumed inside the photoreactor. During the Phase II project, an
automated prototype system will be developed and integrated into a hemodialysis
system. Technical and cost evaluations will be carried out to provide the
foundation for a commercial system.
PROPOSED COMMERCIAL APPLICATION:
Pyrogen-free water is required in all hemodialysis systems. In addition, this technology will find application in other areas of the medical industry: large quantities of pyrogen-free water are required for intravenous infusion fluids, fluids for injection and for irrigation in operating rooms. Also, other industries, such as the hydroponics industry need sterile water.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
1,079 SBIR/STTR records share this UEI (1988–2025). Reported award amounts total $327,411,388. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Energy, National Science Foundation, Environmental Protection Agency
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards